BCR-ABL1 Qpcr-Based Doubling Time Within the First 6 Months after Imatinib Discontinuation is a Predictive of Successful TKI Treatment-Free Remission
BLOOD(2019)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined